A New Name for PCOS? Experts Propose PMOS and Here’s What It Means

For years, Polycystic Ovary Syndrome (PCOS) has been one of the most commonly diagnosed hormonal conditions among women. But now, experts around the world are proposing a major change: a new name that better reflects what the condition actually is.

PCOS may soon be called Polyendocrine Metabolic Ovarian Syndrome (PMOS)—a shift that goes beyond semantics and aims to correct long-standing confusion in women’s health.

Backed by a global consensus published in The Lancet, the proposal brings together findings from thousands of patients, clinicians, and researchers worldwide, all pointing to one issue: the current name does not fully reflect the condition.

Despite its name, PCOS is not simply an “ovarian cyst” condition. Experts emphasize that many women diagnosed with PCOS do not actually have cysts.

A large international health policy review involving over 14,000 patients and health professionals found that the current name is misleading. It places too much emphasis on the ovaries while overlooking the condition’s wider impact on hormones, metabolism, and overall health.

Researchers explain that PCOS is a multisystem condition, affecting not just reproductive health but also metabolism, mental health, and long-term disease risk.

Modern research shows that the condition is linked to a range of health concerns, including:

• Irregular or absent menstrual cycles

• Difficulty with ovulation and fertility challenges

• Insulin resistance and risk of type 2 diabetes

• Weight and metabolic changes

• Acne, excess hair growth, or hair thinning

• Higher risk of anxiety, depression, and reduced quality of life

Experts emphasize that because symptoms vary widely, many women remain undiagnosed for years—sometimes up to 70% of cases go unrecognized.

According to the international review, the term “PCOS” has contributed to several issues in healthcare:

• Delayed or missed diagnosis

• Misunderstanding among patients and even some clinicians

• Stigma linked to fertility and reproductive health

• Fragmented research and inconsistent health policies

By renaming the condition Polyendocrine Metabolic Ovarian Syndrome (PMOS), experts hope to better reflect its hormonal and metabolic nature, making it easier to understand, diagnose, and treat.

The proposed name breaks down the condition more accurately:

• Polyendocrine – involving multiple hormone systems

• Metabolic – affecting how the body processes energy and insulin

• Ovarian – still acknowledging reproductive involvement

• Syndrome – a collection of related symptoms

Importantly, the word “cystic” is removed because research shows that ovarian cysts are not a defining feature of the condition.

This is not just a medical decision made behind closed doors.

The proposed change came from an international consensus process involving doctors, researchers, and patient organizations across different regions. The process included surveys, workshops, and global consultations with more than 14,000 participants.

Health experts say the goal is not to replace one complicated term with another, but to make the condition more accurate, less stigmatized, and easier to understand worldwide.

Click here to learn the signs you might have Polycystic Ovarian Syndrome (PCOS) and what they could mean for your health.